These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 56538)

  • 1. Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals.
    Spehlmann R; Stahl SM
    Lancet; 1976 Apr; 1(7962):724-6. PubMed ID: 56538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems.
    Zhou FM; Wilson C; Dani JA
    Neuroscientist; 2003 Feb; 9(1):23-36. PubMed ID: 12580337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.
    Jellinger KA
    Mol Chem Neuropathol; 1991 Jun; 14(3):153-97. PubMed ID: 1958262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
    Anglade P; Tsuji S; Javoy-Agid F; Agid Y; Hirsch EC
    Ann Neurol; 1995 Feb; 37(2):265-72. PubMed ID: 7847868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of dopamine on acetylcholine release from caudate nucleus.
    Vizi SE; Rónai A; Hársing L; Knoll J
    Pol J Pharmacol Pharm; 1977; 29(3):201-11. PubMed ID: 887499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbances in neurotransmission processes in aging and age-related diseases.
    Ossowska K
    Pol J Pharmacol; 1993; 45(2):109-31. PubMed ID: 8401765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine-dopamine balance hypothesis in the striatum: an update.
    Aosaki T; Miura M; Suzuki T; Nishimura K; Masuda M
    Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S148-57. PubMed ID: 20590830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The degeneration of dopaminergic synapses in Parkinson's disease: A selective animal model.
    Morales I; Sanchez A; Rodriguez-Sabate C; Rodriguez M
    Behav Brain Res; 2015 Aug; 289():19-28. PubMed ID: 25907749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting.
    Agnati LF; Fuxe K; Calza L; Benfenati F; Cavicchioli L; Toffano G; Goldstein M
    Acta Physiol Scand; 1983 Dec; 119(4):347-63. PubMed ID: 6141701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease.
    Arkadir D; Bergman H; Fahn S
    Neurology; 2014 Mar; 82(12):1093-8. PubMed ID: 24663231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.
    Gonzales KK; Smith Y
    Ann N Y Acad Sci; 2015 Sep; 1349(1):1-45. PubMed ID: 25876458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release.
    Berlanga ML; Simpson TK; Alcantara AA
    J Comp Neurol; 2005 Nov; 492(1):34-49. PubMed ID: 16175554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine H
    Varaschin RK; Osterstock G; Ducrot C; Leino S; Bourque MJ; Prado MAM; Prado VF; Salminen O; Rannanpää Née Nuutinen S; Trudeau LE
    Neuroscience; 2018 Apr; 376():188-203. PubMed ID: 29374538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic and Dopaminergic Alterations in Nigrostriatal Neurons Are Involved in Environmental Enrichment Motor Protection in a Mouse Model of Parkinson's Disease.
    Hilario WF; Herlinger AL; Areal LB; de Moraes LS; Ferreira TA; Andrade TE; Martins-Silva C; Pires RG
    J Mol Neurosci; 2016 Dec; 60(4):453-464. PubMed ID: 27660217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
    Hirsch EC
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S115-20; discussion S120-1. PubMed ID: 10762138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
    Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
    Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.
    Bohnen NI; Albin RL; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Frey KA
    JAMA Neurol; 2015 Feb; 72(2):194-200. PubMed ID: 25506674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
    Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
    Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type 1 receptors in rat brain.
    Quirion R; Richard J
    Synapse; 1987; 1(1):124-30. PubMed ID: 3145578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.